Sign Up Now to Download a Free Research Report on AMRN

Sign-Up to Get the Equity Report on this Company Plus Exclusive Access to Our Winning Newsletter Alerts





Download Adobe Reader Having problems viewing PDF files? Download Adobe Reader.

Amarin Corporation Plc

Amarin shares declined 5.75 percent on volume of 11.66 million shares traded to close at $6.39. On Tuesday, rival drug maker, AstraZeneca plc, purchased Omthera Pharmaceuticals Inc. for approximately $260 million. Omthera is currently developing a fish oil-based treatment that could potentially compete with Amarin’s Vascepa.

Going forward ... (see research report)



RESEARCH REPORT ON AMRN Download Free Report Now


Preview Pages of Actual Equity Report

Download Adobe Reader Having problems viewing PDF files? Download Adobe Reader. Research Report on    Research Report on    Research Report on    

Research Report on    Research Report on    Research Report on